Ascendis Pharma A/S (ASND)

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 339.29M EUR in the quarter ending June 30, 2026, with 114.68% growth. This brings the company's total for the last twelve months to 1.05B, up 113.35% year-over-year. In the year 2025, Ascendis Pharma had annual revenue of 720.13M with 98.03% growth. That makes Ascendis Pharma the 6,873rd largest company in the world by revenue and 1,672nd in the United States.

• Revenue (ttm): 1.05B EUR
• Revenue Growth: +113.35%
• P/S Ratio: 14.16
• Revenue / Employee: 880,589 EUR
• Employees: 1,189
• Market Cap: 16.94B USD

Revenue Chart

Chart

Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart

• YORVIPATH 477.41M 66.3%
• SKYTROFA 206.16M 28.6%
• Services and Clinical Supply 18.01M 2.5%
• Milestones 12.92M 1.8%
• Licenses 5.63M 0.8%

By Geography

Chart

• United States 546.39M 75.9%
• Europe 120.95M 16.8%
• Rest of World 52.80M 7.3%

Fiscal year ended Dec 31, 2025 See the full Ascendis Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	720.13M	356.49M	98.03%
Dec 31, 2024	363.64M	96.92M	36.34%
Dec 31, 2023	266.72M	215.54M	421.20%
Dec 31, 2022	51.17M	43.40M	557.93%
Dec 31, 2021	7.78M	825.00K	11.87%
Dec 31, 2020	6.95M	-6.42M	-48.01%
Dec 31, 2019	13.38M	2.79M	26.41%
Dec 31, 2018	10.58M	9.05M	591.57%
Dec 31, 2017	1.53M	-3.08M	-66.78%
Dec 31, 2016	4.61M	-3.51M	-43.26%
Dec 31, 2015	8.12M	-5.87M	-41.94%
Dec 31, 2014	13.98M	-6.43M	-31.48%
Dec 31, 2013	20.41M	4.83M	30.96%
Dec 31, 2012	15.58M	-	-

Data Source: Fiscal.ai Last updated: Aug 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error